GENEPHARM AMLODIPINE amlodipine 5 mg (as besilate) tablet blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

amlodipine besilate, Quantity: 7 mg

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

amlodipine besilate

pharmaceutical_form:

Tablet, uncoated

composition:

Excipient Ingredients: magnesium stearate; lactose monohydrate; microcrystalline cellulose; maize starch

administration_route:

Oral

units_in_package:

30 tablets

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Hypertension - Genepharm Amlodipine is indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. Patients not adequately controlled on a single antihypertensive agent may benefit from the addition of Genepharm Amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. Angina - Genepharm Amlodipine is indicated for the first line treatment of chronic stable angina. Genepharm Amlodipine may be used alone, as monotherapy or in combination with other antianginal drugs.

leaflet_short:

Visual Identification: White to off white, round, scored tablets, engraved AML over score 5 on the other side, APO on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2007-12-13